Cooper Financial Group’s Repligen RGEN Stock Holding History

Cooper Financial Group’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,847	Closed	-$273K	–	303
2020 Q3	$273K	Buy	1,847 +19	+1%	+$2.72K	0.08%	165
2020 Q2	$226K	Buy	+1,828	New	+$215K	0.07%	169

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cooper Financial Group's RGEN Position: Q4 2020 in Review

Cooper Financial Group sold out of Repligen (RGEN) in Q4 2020, closing a stake of 1,847 shares — an estimated $273K sold.

Cooper Financial Group first reported a position in RGEN in Q2 2020 and held it in 2 quarters. The position peaked at $273K in Q3 2020. 449 funds tracked by Wall St. Rank hold RGEN as of Q4 2020.

Cooper Financial Group reported no remaining Repligen position as of Q4 2020 after selling out during the quarter.
Cooper Financial Group sold 1,847 Repligen shares in Q4 2020, an estimated $273K.
Cooper Financial Group first reported a position in Repligen in Q2 2020 and held it in 2 quarters.
Cooper Financial Group's Repligen position peaked at $273K in Q3 2020.
449 funds tracked by Wall St. Rank held Repligen as of Q4 2020.

Based on Cooper Financial Group's 13F filing for Q4 2020, filed 16 Feb 2021.